Antibody-Drug Conjugates for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
Oncology Today with Dr Neil Love
00:00
Rationale for Combining ADCs with Immunotherapy
Sara explains potential synergy: immunogenic cell death, antigen release, and improved T-cell infiltration with ADC+IO.
Play episode from 42:22
Transcript
